Wesdorp, Nina J.
Zeeuw, J. Michiel http://orcid.org/0000-0001-7918-5404
Postma, Sam C. J.
Roor, Joran
van Waesberghe, Jan Hein T. M.
van den Bergh, Janneke E.
Nota, Irene M.
Moos, Shira
Kemna, Ruby
Vadakkumpadan, Fijoy
Ambrozic, Courtney
van Dieren, Susan
van Amerongen, Martinus J.
Chapelle, Thiery
Engelbrecht, Marc R. W.
Gerhards, Michael F.
Grunhagen, Dirk
van Gulik, Thomas M.
Hermans, John J.
de Jong, Koert P.
Klaase, Joost M.
Liem, Mike S. L.
van Lienden, Krijn P.
Molenaar, I. Quintus
Patijn, Gijs A.
Rijken, Arjen M.
Ruers, Theo M.
Verhoef, Cornelis
de Wilt, Johannes H. W.
Marquering, Henk A.
Stoker, Jaap
Swijnenburg, Rutger-Jan
Punt, Cornelis J. A.
Huiskens, Joost
Kazemier, Geert
Funding for this research was provided by:
KWF Kankerbestrijding (14002)
Article History
Received: 10 May 2023
Accepted: 8 September 2023
First Online: 1 December 2023
Declarations
:
: The study was conducted according to the ethical standards of the Helsinki Declaration of 1975 and has been approved by the medical ethical committee (METc VUmc; 23–04-2019 (2019.236)). All included patients signed a written informed consent form, also allowing side studies such as the current one.
: Not applicable.
: CJAP has an advisory role for Nordic Pharma. HAM is a co-founder and shareholder of Nicolab.JS is a member of the <i>European Radiology Experimental</i> Editorial Board. He has not taken part in the review or selection process of this article.All remaining authors declare no competing interests.